Pharvax Biosciences

Pharvax Biosciences is a biotechnology company based in Hyderabad, India, specializing in the development of next-generation recombinant vaccines for animal and human health. The company focuses on addressing critical gaps in infectious disease prevention by utilizing advanced molecular biology and bioprocessing techniques to create thermally stable and cost-effective biologics. Its lead program is a recombinant vaccine for Foot and Mouth Disease (FMD), designed to offer superior safety and efficacy compared to traditional inactivated vaccines. Incubated at the University of Hyderabad, Pharvax leverages its proprietary platform to develop scalable solutions for high-burden diseases in emerging markets. The company is supported by government grants and aims to reduce the global reliance on complex cold-chain logistics for vaccine distribution.